Marie-Cécile Didiot University of Massachusetts Medical School, United States
2 protocols

Anastasia Khvorova RNA Therapeutics Institute, University of Massachusetts Medical School, USA
2 protocols

Lauren Hall RNA Therapeutics Institute, University of Massachusetts Medical School, USA
1 protocol

Andrew Coles RNA Therapeutics Institute, University of Massachusetts Medical School, USA
2 protocols

Neil Aronin
  • RNA Therapeutics Institute, University of Massachusetts Medical School, USA
  • 2 Author merit
2 Protocols published
A High-throughput Assay for mRNA Silencing in Primary Cortical Neurons in vitro with Oligonucleotide Therapeutics
Primary neurons represent an ideal cellular system for the identification of therapeutic oligonucleotides for the treatment of neurodegenerative diseases. However, due to the sensitive nature of primary cells, the transfection of small interfering ...
Loading of Extracellular Vesicles with Chemically Stabilized Hydrophobic siRNAs for the Treatment of Disease in the Central Nervous System
Authors:  Reka A. Haraszti, Andrew Coles, Neil Aronin, Anastasia Khvorova and Marie-Cécile Didiot, date: 06/20/2017, view: 3001, Q&A: 0
Efficient delivery of oligonucleotide therapeutics, i.e., siRNAs, to the central nervous system represents a significant barrier to their clinical advancement for the treatment of neurological disorders. Small, endogenous extracellular ...
您可以切换至中文站点,以获得适用于中国用户的内容 中文站点
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.